相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Covid-19's Devastating Effect on Tuberculosis Care - A Path to Recovery
Madhukar Pai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Moxifloxacin Pharmacokinetics, Cardiac Safety, and Dosing for the Treatment of Rifampicin-Resistant Tuberculosis in Children
Kendra K. Radtke et al.
CLINICAL INFECTIOUS DISEASES (2022)
Compassionate use of delamanid in adults and children for drug-resistant tuberculosis: 5-year update
Sambuddha Ghosh et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Bedaquiline for multidrug-resistant TB in paediatric patients
R. Moodliar et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2021)
Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial
Kelly E. Dooley et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
Francesca Conradie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial
Greg J. Fox et al.
BMJ OPEN (2020)
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study
Alexandra B. Hogan et al.
LANCET GLOBAL HEALTH (2020)
How TB and COVID-19 compare: an opportunity to integrate both control programmes
G. Echeverria et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2020)
Acceptability of levofloxacin, moxifloxacin and linezolid among children and adolescents treated for TB
J. L. Winckler et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2020)
Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis
Amyn A. Malik et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis
Andrew J. Nunn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies
Anthony J. Garcia-Prats et al.
PLOS MEDICINE (2019)
Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Payam Nahid et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Pharmacokinetics, Safety, and Dosing of Novel Pediatric Levofloxacin Dispersible Tablets in Children with Multidrug-Resistant Tuberculosis Exposure
Anthony J. Garcia-Prats et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Pharmacokinetics of Second-Line Antituberculosis Drugs in Children with Multidrug-Resistant Tuberculosis in India
Agibothu Kupparam Hemanth Kumar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children
A. J. Garcia-Prats et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2018)
Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis
Elizabeth P. Harausz et al.
PLOS MEDICINE (2018)
Potential effect of household contact management on childhood tuberculosis: a mathematical modelling study
Peter J. Dodd et al.
LANCET GLOBAL HEALTH (2018)
Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)
James A. Seddon et al.
TRIALS (2018)
Levofloxacin Population Pharmacokinetics in South African Children Treated for Multidrug-Resistant Tuberculosis
Paolo Denti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The global burden of tuberculosis mortality in children: a mathematical modelling study
Peter J. Dodd et al.
LANCET GLOBAL HEALTH (2017)
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
Jay Achar et al.
EMERGING INFECTIOUS DISEASES (2017)
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis
Suzanne M. Marks et al.
CLINICAL INFECTIOUS DISEASES (2017)
Global burden of drug-resistant tuberculosis in children: a mathematical modelling study
Peter J. Dodd et al.
LANCET INFECTIOUS DISEASES (2016)
Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts A Cost-Effectiveness Analysis
Gregory J. Fox et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)
Pharmacokinetics and Safety of Moxifloxacin in Children With Multidrug-Resistant Tuberculosis
Stephanie Thee et al.
CLINICAL INFECTIOUS DISEASES (2015)
Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates
Helen E. Jenkins et al.
LANCET (2014)
A refined symptom-based approach to diagnose pulmonary tuberculosis in children
Ben J. Marais et al.
PEDIATRICS (2006)
The bacteriologic yield in children with intrathoracic tuberculosis
BJ Marais et al.
CLINICAL INFECTIOUS DISEASES (2006)
A proposed radiological classification of childhood intra-thoracic tuberculosis
BJ Marais et al.
PEDIATRIC RADIOLOGY (2004)
分享论文
